Publications by authors named "Eric Vail"

Claim this Profile
A
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial.
Linda K Zane, Laura M Yee, Ting-Chia Chang, Jeffrey Sklar, Guangxiao Yang, Eric Vail

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, Association of Cancer Care Centers, and College of American Pathologists.
Susan J Hsiao, Destin Black, Kelly A Devereaux, Ian S Hagemann, Lawrence J Jennings, Eric Vail

J Mol Diagn· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo RUNX1-driven acute myeloid leukemia requiring integrative genetics.
Celeste C Eno, Jeremy Lorber, Eric Vail, Rhona Schreck

Cancer Genet· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early cardio-oncology intervention in thoracic radiotherapy: prospective single-arm pilot study.
Samuel C Zhang, Jordan O Gasho, Celeste Eno, Katrina D Silos, Felicity Pendergast, Eric Vail

Commun Med (Lond)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of a rare case of high-grade B-cell lymphoma with MYC, BCL2, BCL6, and CCND1 rearrangements.
Fnu Monika, Ahmed Sabri, David Cantu, Eric Vail, Andrew Siref

J Hematop· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical validation of the LungLB test: a 4-color fluorescence in-situ hybridization assay for the evaluation of indeterminate pulmonary nodules.
Michelle L Lutman, Daniel Gramajo-Leventon, Shahram Tahvilian, Lara Baden, Courtney L Gilbert, Eric Vail

BMC Pulm Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two distinct pathogenic pathways of digital papillary adenocarcinoma - BRAF mutation or low-risk HPV infection.
Chau M Bui, Tatsiana Pukhalskaya, Bruce R Smoller, Hatice Betul Zengin, Saleh Heneidi, Eric Vail

J Cutan Pathol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of visible low-grade dysplastic lesions in patients with inflammatory bowel disease.
Deepti Dhall, Elias Makhoul, Roberto Taguibao, Kevin Waters, Wenjuan Zhang, Eric Vail

Hum Pathol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
Albrecht Stenzinger, Brian Cuffel, Noman Paracha, Eric Vail, Jesus Garcia-Foncillas

Oncologist· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Expression Profiling of Fibroepithelial Lesions of the Breast.
Xiaomo Li, Eric Vail, Horacio Maluf, Manita Chaum, Matthew Leong

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission risk of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) to healthcare personnel following unanticipated exposure to aerosol-generating procedures: Experience from epidemiologic investigations at an academic medical center.
Sharon E Fawcett, Meghan S Madhusudhan, Emily N Gaddam, Matthew J Almario, Shawna R Masih, Eric Vail

Infect Control Hosp Epidemiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.
Saleh Heneidi, Jeffrey A Golden, Eric Vail

Cancer J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC-Nonamplified Secondary Lymphatic-Type Angiosarcoma With Prominent Lymphocytic Infiltrate Following Radiation Therapy for Myxoid Liposarcoma.
Andrea Krajisnik, Bonnie L Balzer, Eric Vail, Earl Brien, Wonwoo Shon

Am J Dermatopathol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Severe Acute Respiratory Syndrome Coronavirus 2 Epsilon Variant: Highly Transmissible but With an Adjusted Muted Host T-Cell Response.
Jasmine T Plummer, Deisy Contreras, Wenjuan Zhang, Aleksandra Binek, Ruan Zhang, Eric Vail

Clin Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series - COVID-19 is unlikely to affect male fertility: Results of histopathological and reverse transcriptase polymerase chain reaction analysis.
John M Masterson, Chau Bui, Wohaib Hasan, Yi Zhang, Carissa Huynh, Eric Vail

Can Urol Assoc J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Application of Next-Generation Sequencing Identifies Pancreatic Mass as Metastasis From an EGFR-Mutated Lung Adenocarcinoma.
Luxi Chen, John Davelaar, Srinivas Gaddam, Kambiz Kosari, Nicholas Nissen, Eric Vail

J Natl Compr Canc Netw· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Upper Respiratory Tract Transcriptomic Profiling Reveals a Potential Role of Early Activation of Interferon Pathway in Severe COVID-19.
Shabir A Bhat, Tomohiro Shibata, Matthew Leong, Jasmine Plummer, Eric Vail

Viruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC.
Tomohiro Shibata, Duo-Yao Cao, Tahir B Dar, Faizan Ahmed, Shabir A Bhat, Eric Vail

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KMT2A-CBL fusion in rapidly progressive myeloid disorder.
Manita Chaum, Eric Vail, Rhona Schreck, Jeremy Lorber, Celeste C Eno

Cancer Genet· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Over-Expression Varies in Different Subtypes of Lung Cancer: Will This Affect Future Therapies?
Asad Ullah, Steven Pulliam, Nabin Raj Karki, Jaffar Khan, Sana Jogezai, Eric Vail

Clin Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal Stromal Tumors (GIST): A Population-Based Study Using the SEER Database, including Management and Recent Advances in Targeted Therapy.
Jaffar Khan, Asad Ullah, Abdul Waheed, Nabin Raj Karki, Nawaraj Adhikari, Eric Vail

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting the "undetectable" alterations: Use of NGS to uncover high-risk alterations.
Chelsea Halprin, Sumire Kitahara, Eric Vail, Celeste C Eno

Cancer Genet· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination.
Samuel D Stampfer, Marissa-Skye Goldwater, Sean Bujarski, Bernard Regidor, Wenjuan Zhang, Eric Vail

Clin Infect Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma.
Mary Wong, Jong T Kim, Brian Cox, Brent K Larson, Stacey Kim, Eric Vail

Hepat Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient With Stage IV NSCLC and CNS Metastasis With EGFR Exon 18-25 Kinase Domain Duplication With Response to Osimertinib as a First-Line Therapy.
Jong Taek Kim, Wenjuan Zhang, Jean Lopategui, Eric Vail, Ani Balmanoukian

JCO Precis Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis